213 related articles for article (PubMed ID: 34670170)
21. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
Eapen M; Rocha V; Sanz G; Scaradavou A; Zhang MJ; Arcese W; Sirvent A; Champlin RE; Chao N; Gee AP; Isola L; Laughlin MJ; Marks DI; Nabhan S; Ruggeri A; Soiffer R; Horowitz MM; Gluckman E; Wagner JE; ; ;
Lancet Oncol; 2010 Jul; 11(7):653-60. PubMed ID: 20558104
[TBL] [Abstract][Full Text] [Related]
22. Matched versus Haploidentical Hematopoietic Stem Cell Transplantation as Treatment Options for Primary Immunodeficiencies in Children.
Holzer U; Döring M; Eichholz T; Ebinger M; Queudeville M; Turkiewicz D; Schwarz K; Handgretinger R; Lang P; Toporski J
Transplant Cell Ther; 2021 Jan; 27(1):71.e1-71.e12. PubMed ID: 32966882
[TBL] [Abstract][Full Text] [Related]
23. Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis.
Mushtaq MU; Shahzad M; Tariq E; Iqbal Q; Chaudhary SG; Zafar MU; Anwar I; Ahmed N; Bansal R; Singh AK; Abhyankar SH; Callander NS; Hematti P; McGuirk JP
Front Oncol; 2022; 12():1005042. PubMed ID: 36276084
[TBL] [Abstract][Full Text] [Related]
24. Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation.
Mahadeo KM; Tewari P; Parikh SH; Driscoll TA; Page K; Martin PL; Kurtzberg J; Prasad VK
Pediatr Transplant; 2015 Nov; 19(7):753-7. PubMed ID: 26369627
[TBL] [Abstract][Full Text] [Related]
25. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell transplant with HLA-mismatched grafts: impact of donor, source, conditioning, and graft versus host disease prophylaxis.
Metheny L; de Lima M
Expert Rev Hematol; 2019 Jan; 12(1):47-60. PubMed ID: 30582393
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts.
Lu Y; Xiong M; Sun RJ; Zhao YL; Zhang JP; Cao XY; Liu DY; Wei ZJ; Zhou JR; Lu DP
Hematology; 2021 Dec; 26(1):134-143. PubMed ID: 33491597
[No Abstract] [Full Text] [Related]
28. Post-Transplantation Cyclophosphamide-Based Haploidentical versus Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia.
Hong KT; Park HJ; Kim BK; An HY; Choi JY; Kang HJ
Transplant Cell Ther; 2022 Apr; 28(4):195.e1-195.e7. PubMed ID: 35021131
[TBL] [Abstract][Full Text] [Related]
29. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
Szydlo R; Goldman JM; Klein JP; Gale RP; Ash RC; Bach FH; Bradley BA; Casper JT; Flomenberg N; Gajewski JL; Gluckman E; Henslee-Downey PJ; Hows JM; Jacobsen N; Kolb HJ; Lowenberg B; Masaoka T; Rowlings PA; Sondel PM; van Bekkum DW; van Rood JJ; Vowels MR; Zhang MJ; Horowitz MM
J Clin Oncol; 1997 May; 15(5):1767-77. PubMed ID: 9164184
[TBL] [Abstract][Full Text] [Related]
30. HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis.
Robin M; Porcher R; Ruggeri A; Blaise D; Wolschke C; Koster L; Angelucci E; Stölzel F; Potter V; Yakoub-Agha I; Koc Y; Ciceri F; Finke J; Labussière-Wallet H; Cascon MJP; Verbeek M; Rambaldi A; Cornelissen JJ; Chevallier P; Radia R; Nagler A; Fegueux N; Gluckman E; de Witte T; Kröger N
Biol Blood Marrow Transplant; 2019 Jan; 25(1):114-120. PubMed ID: 30172776
[TBL] [Abstract][Full Text] [Related]
31. Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.
Hammami MB; Verceles JA; Goldfinger M; Shah N; Sica RA; Mantzaris I; Kornblum N; Konopleva M; Shastri A; Shapiro LC; Feldman EJ; Gritsman K; Verma A; Cooper DL
Transplant Cell Ther; 2024 May; 30(5):544.e1-544.e8. PubMed ID: 38417677
[TBL] [Abstract][Full Text] [Related]
32. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
33. HSCT with mismatched unrelated donors: Bone marrow versus peripheral blood stem cells sources in pediatric patients.
Berger M; Barone M; Spadea M; Saglio F; Pessolano R; Fagioli F
Pediatr Transplant; 2022 Jun; 26(4):e14233. PubMed ID: 35092128
[TBL] [Abstract][Full Text] [Related]
34. No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.
Schober SJ; Hallmen E; Reßle F; Gassmann H; Prexler C; Wawer A; von Luettichau I; Ladenstein R; Kazanowska B; Ljungman G; Niggli F; Lohi O; Hauer J; Gruhn B; Klingebiel T; Bader P; Burdach S; Lang P; Sparber-Sauer M; Koscielniak E; Thiel U
Front Oncol; 2022; 12():878367. PubMed ID: 35619911
[TBL] [Abstract][Full Text] [Related]
35. [Molecular diagnosis and hematopoietic stem cell transplantation in 17 children with inherited bone marrow failure syndrome].
Li Q; Li B; Luo C; Wang J; Luo C; Ding L; Chen J
Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):817-23. PubMed ID: 26758319
[TBL] [Abstract][Full Text] [Related]
36. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
[TBL] [Abstract][Full Text] [Related]
37. One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.
Valcárcel D; Sierra J; Wang T; Kan F; Gupta V; Hale GA; Marks DI; McCarthy PL; Oudshoorn M; Petersdorf EW; Ringdén O; Setterholm M; Spellman SR; Waller EK; Gajewski JL; Marino SR; Senitzer D; Lee SJ
Biol Blood Marrow Transplant; 2011 May; 17(5):640-8. PubMed ID: 20674756
[TBL] [Abstract][Full Text] [Related]
38. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
39. Congenital amegakaryocytic thrombocytopenia: a case report of pediatric twins undergoing matched unrelated bone marrow transplantation.
Rao AA; Gourde JA; Marri P; Galardy PJ; Khan SP; Rodriguez V
J Pediatr Hematol Oncol; 2015 May; 37(4):304-6. PubMed ID: 25171451
[TBL] [Abstract][Full Text] [Related]
40. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.
Zhang MJ; Davies SM; Camitta BM; Logan B; Tiedemann K; Eapen M; Thiel EL
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1204-10. PubMed ID: 22406037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
